Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boehringer Ingelheim today announced the signing of an option to acquire Trutino Biosciences Inc. (the “Transaction”), a San Diego-based biotech company. Trutino Biosciences is a pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat ...
Boehringer Ingelheim enters global licensing agreement to develop and commercialize innovative antibodies from A*STAR for targeted cancer therapies
Scoop Community provides New Zealand Community news and views
Learn more about a new program sponsored by Boehringer Ingelheim and hosted by EQUUS that will distribute equine disease information from the EDCC throughout the industry
Learn more about a new program sponsored by Boehringer Ingelheim and hosted by EQUUS that will distribute equine disease information from the EDCC throughout the industry